Fig. 2From: The changing landscape of drug clinical trials on cardiometabolic diseases in China, 2009–2021 Annual numbers of initiated cardiometabolic drug clinical trials by major indications in China, 2009–2021 The data ends in July 1st, 2021Back to article page